Co-Founder, Board Member

Labcorp, Natera Reach Settlement in Genetic Testing Patent Dispute

Natera Insider Sold Shares Worth $9,016,668, According to a Recent SEC Filing

Natera initiated with neutral view at Wells Fargo, here's why

Natera Executive Chairman Matthew Rabinowitz Sells 50,000 Shares

Director, Strategy and Market Development

Natera is redefining the future of therapeutics by integrating AI with healthcare to create next-generation treatment modalities. The Director, Strategy and Market Development will lead the positioning and go-to-market strategy for AI-enabled therapeutic offerings, engaging with BioPharma partners and collaborating with internal teams to ensure effective delivery and market understanding.

Vice President RCM Strategy

Director, Biopharma Business Development

Director, Business Development - BioPharma

V.P. Business Development

Strategic Alliances Director

Sign up with Google

Sign in with Google